Healthcare News - An Overview
FTC sues big pharmacy gain administrators about insulin prices The agency introduced motion versus Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the record cost of daily life-saving insulin prescription drugs.Pay attention to the posting 10 min This audio is